The growth expected for robotic surgery is astounding. Allied Markets Research predicts demand could reach $98,737.0 million by 2024.
The prospects for such surgery will be examined in the upcoming BIOMEDevice San Jose panel discussion What's Next for Robotic Surgery? to be held December 5. Participants include David Fischel, chairman and CEO at Stereotaxis; John H. Kirk, surgeon at St. Helena Women's Center; Javad Mokhbery, CEO and founder at FUTEK Advanced Sensor Technology; and Scott Thielman, CTO at Product Creation Studio, who will moderate the discussion. Thielman holds a Ph.D. in mechanical engineering from the University of Washington and is a licensed professional engineer, and he has participated in all aspects of product development for clients.
“I’m excited about the panel composition,” Thielman told MD+DI. “We have the CEO/investor of an amazing intra-vascular robotic system (Fischel from StereoTaxis), we have the CEO/founder of an advanced sensor company (Mokhbery from FUTEK), and we have an expert surgical robotic practitioner (physician Kirk at Saint Helena Women’s Center). This cuts across the areas that will drive innovation in this space. It’s a race for advanced surgery systems to apply cutting-edge technologies to better meet the needs of the users, so I’ve got a representative at each of these touchpoints.”
To understand the future of such robotic surgery, Thielman said that it is important to examine the past and present. “I plan to briefly discuss the current state of the art, for surgeon experience and technical capabilities, as a springboard for jumping into the future,” he said. “An understanding of user need always tends to illuminate the areas that need innovative thinking. I want to hear how much automation physicians want and how much the technologists think they can deliver in the near term.”
He also wants to look well into the future. “The topic of robotic surgery still feels ‘space-aged’ to me so I want to learn what the moonshot ideas are,” Thielman said. “What do we think robotic surgery will look like in a decade or two? Will there still be a surgeon involved? And I think the audience can add a lot of flavor to this discussion. The halls of BIOMEDevice are packed with forward thinkers and innovators so I expect points of view on regulatory, AI, security, liability, and reimbursement to be flying around. It should be a fun ride.”
Topics to be covered include:
- How the market is responding to new surgical robotics technologies.
- The impact of surgical robotics on biomaterials innovation.
- How both surgeon and patient-centric focus has changed design.
- New surgical robotics innovations in the next decade.
- Bringing the sense of touch to surgical robots.